Ken Fisher's position in Boston Scientific is currently worth $269 Million. That's 0.14% of their equity portfolio (110th largest holding). The first Boston Scientific trade was made in Q4 2018. Since then Ken Fisher bought shares nineteen more times and sold shares on one occasions. The stake costed the investor $159 Million, netting the investor a gain of 69% so far.
Key Players: Leading players profiled in the Medical Supplies Market report include Thermo Fisher Scientific Inc. (US), Halyard Health, Inc. (US), Baxter Int...
OpenPR, over 1 year agoWireless Brain Implant is a device that could provide deep insight into the mechanisms of pain, depression, addiction, and certain diseases by observing the ...
OpenPR, over 3 years ago